Physician profile
Stuart P Adler
NPI 1417050840
$34,120.39
in general payments reported to CMS, 2019-2025
6 companies · $44.82 in 2025
The $44.82 reported for 2025 was less than what a typical Pediatric Infectious Diseases provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $17K · 2021: $3,850 · 2024: $1,641 · 2025: $44.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,641 · Food and Beverage: $44.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,640.85 |
| Food and Beverage | $44.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saol International Limited | $15,000.00 | 2020 | |
| Merck Sharp & Dohme LLC | $13,539.09 | 2019-2021 | |
| Saol Therapeutics INC. | $2,295.63 | 2019 | |
| Biotest Ag | $1,640.85 | 2024 | |
| Modernatx, INC. | $1,600.00 | 2021 | |
| Biosense Webster, INC. | $44.82 | 2025 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.